BLOG

Novartis & Google to Develop Contact Lens That Monitors Blood Sugar

Google and Novartis announced this week that they're to develop a smart contact lens with the potential to monitor the wearer’s blood sugar levels.

Novartis said that Alcon, its eye care unit, had struck a deal to license so-called smart lens technology from one of Google’s research divisions. Financial terms were not disclosed. Alcon (formerly CIBA Vision) offer comprehensive eye health and vision care products globally.

As part of the agreement, Alcon said it would look to create products from Google’s prototype smart contact lens, which uses miniature sensors and a radio antenna thinner than a human hair to track glucose levels. The companies did not specify how the data would be transmitted.

Information about blood sugar levels, which is particularly useful for people with diabetes, could be uploaded to smartphone devices and used by doctors and patients to monitor the data almost in real time, according to a statement from Google issued when the company released its prototype in January.

Joe Jimenez, the chief executive of Novartis, said that product was not as far along in development, and that both lenses were still early in their development.

“It’s not going to happen overnight,” he said. “This will take a few years, as opposed to a few months.”

Mr. Jimenez declined to disclose financial details of the deal. He also said that it was too early to estimate what such lenses, if they are eventually approved, would cost.

Sergey Brin, a Google founder, said the company’s smart lens technology could “help improve the quality of life for millions of people.”

The push to develop medical technology comes as several of the world’s largest technology companies are looking for new areas for growth. Analysts say that the pharmaceutical and health care sectors are crucial targets as people increasingly take greater control of their own medical treatment.

National Sunglasses Day

Friday, 4 July 2014
National Sunglasses Day The United States Congress recognises National Sunglasses Day.

The Vision Council and optical industry (in the US) have been promoting and educating consumers about the damaging effects of UV rays for sometime now. Last week the United States Congress have passed 'National Sunglasses Day' to fall on the 27th of June and officially entered National Sunglasses Day into the Congressional record.

It's great to see America leading the way and promoting wearing UV protective eyewear while encouraging others to do the same.

Australia has promoted the same message in the past but we are yet to make the day official. In 2011 the Queensland Eye Institute launched an exciting new education program aimed at raising awareness and the damaging effects of UV rays (especially within Australia.)

Australia has the highest sunglasses standards in the world and wearing your "sunnies" will protect you from harmful ultraviolet (UV) light.

Exposure to ultraviolet (UV) radiation can damage your eyes, and repeated exposure can cause a range of short-term and long-term issues including:

  • Excessive blinking
  • Swelling or difficulty looking at strong light
  • Acute photokeratopathy (sunburn of the cornea or snow-blindness).
  • Cataracts (cloudiness of the lens)
  • Pterygium (an overgrowth of the conjunctiva on to the cornea)
  • Solar keratopathy (cloudiness of the cornea)
  • Cancer of the conjunctiva (the membrane covering the white part of the eye)
  • Skin cancer of the eyelids and around the eyes.


Remember to wear your sunnies when outdoors, driving or exposed to UV light.



of National Sunglasses Day recognized by The Vision Council and optical industry as taking place today, June 27, 2014 - See more at: http://www.visionmonday.com/latest-news/article/congress-recognizes-june-27-as-national-sunglasses-day-applauds-vision-council-and-sunglass-manufacturers-for-uv-education-efforts-1/#sthash.axXEtB3a.dpuf
Optometrist appointed chair of Notre Dame’s Medical School Advisory Board

You're in good, experienced hands, Mylens customers!

--

Mylens Optical's optometrist Mr Paul Sheehan has been appointed chairman of the Medical School Advisory Board at Notre Dame University in Sydney. Mr Sheehan is the first optometrist in Australia to be appointed to such a position. He has held a variety of positions since graduating in optometry from the University of New South Wales in 1979. including heading up NIB Eyecare in Newcastle, being a co-founder and director of Union Optical in Melbourne, and a co-founder and director of Mylens, a contact-lens supply company based in Sydney.

Through his contacts within the union movement and government, in 1993 Mr Sheehan played the major role in preventing benefits for optometrical consultations being dropped by Medicare, a role that has never been acknowledged by Optometrists Association Australia. He was a member of the New South Wales Board of Optometrical Registration in the early 1990s. Currently he is a director of Metro Dental in Melbourne (from January 2011) and a director of Mylens Optical, based in Artarmon, Sydney, which is an online optical business selling contact lenses, prescription glasses and sunglasses. He has been a director of Smart Eyes Melbourne and Charlestown since January 2006 and a director of Yangoda for 22 years. Yangoda is an ancillary health advisory company which established medical, optical and dental services primarily for health-insurance funds and universities around Australia. His consultancy work has included AHM, HCF, NIB, Teachers Health, Peoplecare and Rt Health Funds over 29 years. He was managing director of Optifashion Australia (August2007-November 2009). Optifashion Australia was the company through which Safilo SpA of Italy established 68 retail stores in Australia.

12345